ICO Information Centre on HPV and Cancer

Thailand
Human Papillomavirus and Related Cancers, Fact Sheet 2016 (2016-12-15)
I. Key data on HPV and HPV-related cancers
Thailand has a population of Figure 1. Comparison of the ten most frequent HPV
28.59 millions women ages 15 oncogenic types in Thailand among women with
years and older who are at risk of and without cervical lesions
developing cervical cancer. Cur- 16 2.1

Normal cytology(3, 4)
33 1.6
rent estimates indicate that every 18 1.3

HPVtype
58 1.1
year 8184 women are diagnosed 31 1.1

with cervical cancer and 4513 die 70

45
0.6
0.4
from the disease. Cervical cancer ranks as the 2nd most fre- 51 0.2
56 0.2
quent cancer among women in Thailand and the 2nd most 39 0.2

frequent cancer among women between 15 and 44 years of

16 18.1

Lowgrade lesions(5, 6)
age. About 3.4% of women in the general population are esti- 52 14.5

mated to harbour cervical HPV-16/18 infection at a given time, 51 10.2

HPVtype
39 9.4
and 67.6% of invasive cervical cancers are attributed to HPVs 58 8.5
68 7.5
16 or 18. 56 7.4
18 7.3
31 7.1
33 5.7

24.3

Highgrade lesions(7, 8)
16
52 17.4
Table 1. Crude incidence rates of HPV-related 58 9.4

HPVtype
26 5.4
cancers 18 5.4
53 5.3
Male Female 33 4.8
31 4.4
Cervical cancer - 23.0 68 4.0
45 3.8
Anal cancer 0.1-0.3 0.1-0.4
Vulva cancer - 0.2-1.1 16 53.2
Cervical Cancer(1, 2)

18 14.4
Vaginal cancer - 0.1-0.3 58 9.8
HPVtype

52 6.2
Penile cancer 0.4-1.9 - 45 4.4
33 4.2
Pharynx (excluding nasopharynx) 3.2 0.6 35 2.4
31 1.9
Please refer to country report for data sources
59 1.8
39 1.6

0 10 20 30 40 50 60

Table 2. Burden of cervical cancer Prevalence (%)

Incidence Mortality
Annual number of new cases/deaths 8184 4513
Crude rate 23.0 12.7
Age-standarized rate 17.8 9.7
Cumulative risk 0-74 years (%) 1.8 1.0
Ranking of cervical cancer (all years) 2nd 4th
Ranking of cervical cancer (15-44 years) 2nd 2nd

Table 3. Burden of cervical HPV infection Thailand

No. Tested % (95% CI)
HPV prevalence in women with normal
cytology 26269 6.9 (6.6-7.2)
HPV 16/18 prevalence:
Normal cytology 5693 3.4 (3.0-3.9)
Low-grade cervical lesions 436 25.5 (21.6-29.7)
High-grade cervical lesions 753 29.7 (26.6-33.1)
Cervical cancer 1786 67.6 (65.4-69.7)

For data sources and further data on HPV infection in cancer sites other than the cervix, please refer to the specific country summary report.
 ICO Information Centre on HPV and Cancer

Thailand
Human Papillomavirus and Related Cancers, Fact Sheet 2016 (2016-12-15)
II. Complementary data on cervical cancer prevention
Table 4. Factors contributing to cervical cancer (co- Table 7. Cervical screening practices and
factors) recommendations
Smoking prevalence (%), women 2.4 Cervical cancer screen- 60.2% (All women aged 30-59
ing coverage, % (age and screened every 5y, RHS 2009 Thai-
Total fertility rate (live births per women) 1.4 screening interval, reference) land)
Hormonal contraception use (%) (pill, injectable 49.4 Screening ages (years) 30-65
or implant), among women
Screening interval (years) or 5 years
HIV prevalence (%), adults (15-49 years) 1.1 [1.0 - 1.3]
frequency of screens

Table 5. Sexual behaviour Figure 2. Estimated coverage of cervical cancer

MEN screening in Thailand, by age and study
Percentage of 15-year-old who have had sexual -
intercourse 100

Range of median age at first sexual intercourse -

WOMEN 80

Percentage of 15-year-old who have had sexual -

Estimated cervical cancer screening coverage (%)
intercourse
60
Range of median age at first sexual intercourse -
No data available

40

Table 6. HPV vaccine introduction

HPV vaccination programme Pilot program
20
Date of HPV vaccination routine -
immunization programme start
HPV vaccination target age for routine - 0

immunization
Full course HPV vaccination coverage for Please refer to country report for data sources.
routine immunization:
% (calendar year) -

Contact information:

ICO HPV Information Centre

Institut Catal dOncologia
Avda. Gran Via de lHospitalet, 199-203
08908 LHospitalet de Llobregat (Barcelona, Spain)
e-mail: info@hpvcentre.net
internet adress: www.hpvcentre.net

For data sources and further data on HPV infection in cancer sites other than the cervix, please refer to the specific country summary report.